Synlab AG
XETRA:SYAB
Relative Value
There is not enough data to reliably calculate the relative value of SYAB.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SYAB Competitors Multiples
Synlab AG Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Synlab AG
XETRA:SYAB
|
2.4B EUR | 0.9 | 27.1 | 8.2 | 51.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.4B USD | 0.2 | 56.2 | 14.2 | 14.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
77.8B USD | 0.3 | 12.7 | 0 | 0 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
65.2B EUR | 0.3 | 12.5 | 8 | 10.1 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
29.3B EUR | 1.3 | 25.5 | 11.1 | 16.8 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
24.1B EUR | 1.2 | 33.4 | 10.5 | 22.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.1B USD | 1.7 | 26.9 | 14.4 | 20.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.6B USD | 2.1 | 23 | 12.6 | 17 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
12.1B EUR | 0.6 | 16.5 | 6.5 | 13.9 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
13.5B USD | 14.9 | -33.7 | -35.5 | -32.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 0.8 | 13.9 | 7.3 | 9.9 |